• Explore /
  • Poster
  • / Patient-reported outcomes (PROs) in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab (D) plus carboplatin/paclitaxel (CP) compared with CP in the ENGOT-EN6/GOG3031/RUBY trial.

Patient-reported outcomes (PROs) in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab (D) plus carboplatin/paclitaxel (CP) compared with CP in the ENGOT-EN6/GOG3031/RUBY trial.

Abstract Poster

Authors

Mansoor Mirza

Mansoor Raza Mirza

Rigshospitalet, Copenhagen University Hospital, Denmark, Nordic Society of Gynaecologic Oncology–Clinical Trial Unit, Copenhagen, Denmark

Mansoor Raza Mirza, Mark S. Shahin, Matthew A. Powell, Caroline Lundgren, Vladyslav Sukhin, Bhavana Pothuri, Lucy Gilbert, Sarah Gill, Graziana Ronzino, Nicole Suzanne Nevadunsky, Stefan Kommoss, Lyndsay Willmott, Ingrid Boere, Cara Amanda Mathews, Joseph Buscema, Michael Teneriello, Oren Meyers, Jamie Garside, Robert L. Coleman, Brian M. Slomovitz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship

Sub Track

Integrating Patient Experience Assessment and Patient Reported Outcomes Into Practice

Clinical Trial Registration Number

NCT03981796

Citation

JCO Oncol Pract 19, 2023 (suppl 11; abstr 332)

DOI

10.1200/OP.2023.19.11_suppl.332

Abstract #

332

Poster Bd #

E17

Abstract Disclosures

Similar Posters

First Author: Mansoor Raza Mirza

First Author: Mansoor Raza Mirza

First Author: Jennifer Hanlon

First Author: Ignace Vergote